tiprankstipranks
Serina Therapeutics (SER)
:SER
US Market
SER
Serina Therapeutics
RESEARCH TOOLSreports

Serina Therapeutics (SER) Financial Statements

258 Followers

Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently $24.38M. The company's EPS TTM is $-0.31; its P/E ratio is -1.01; Serina Therapeutics is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 130.00K$ 56.00K$ 3.15M$ 500.00K$ 3.46M
Gross Profit$ 45.00K$ -138.00K$ 3.06M$ 500.00K$ -333.84K
Operating Income$ -24.02M$ -17.05M$ -3.13M$ -2.27M$ -1.63M
EBITDA$ -24.02M$ -10.49M$ 5.92M$ -2.60M$ -1.23M
Net Income$ -19.18M$ -11.14M$ 5.27M$ -2.68M$ -1.26M
Balance Sheet
Cash & Short-Term Investments$ 3.06M$ 3.67M$ 7.62M$ 645.00K$ 584.00K
Total Assets$ 6.95M$ 6.72M$ 8.97M$ 3.24M$ 3.15M
Total Debt$ 196.00K$ 268.00K$ 3.44M$ 18.12M$ 13.20M
Net Debt$ -2.86M$ -3.40M$ -4.17M$ 17.48M$ 12.62M
Total Liabilities$ 6.99M$ 6.22M$ 41.26M$ 20.56M$ 15.03M
Stockholders' Equity$ -37.00K$ 641.00K$ 4.11M$ -17.21M$ -11.83M
Cash Flow
Free Cash Flow$ -17.95M$ -17.16M$ -2.98M$ -2.09M$ -2.36M
Operating Cash Flow$ -17.95M$ -17.14M$ -2.48M$ -2.08M$ -2.25M
Investing Cash Flow$ -59.00K$ -22.00K$ -504.00K$ 980.94K$ 823.32K
Financing Cash Flow$ 17.41M$ 13.21M$ 10.07M$ 1.31M$ 1.08M
Currency in USD

Serina Therapeutics Earnings and Revenue History

Income Statement >

Serina Therapeutics Debt to Assets

Balance Sheet >

Serina Therapeutics Cash Flow

Cash Flow >

Serina Therapeutics Forecast EPS vs Actual EPS

Earnings >